Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: A pilot study

Journal of Urology

Volumn 162, Issue 4, 1999, Pages 1314-1317

  Perrotti, Michael ^a,b   Han, Ken Ryu ^a   Epstein, Robert E ^a   Kennedy, Eugene C ^a   Rabbani, Farhang ^a   Badani, Ketan ^a   Pantuck, Allan J ^a   Weiss, Robert E ^a   Cummings, Kenneth B ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Division of Urology   (United States)

Author keywords

Biopsy; Magnetic resonance imaging; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CLINICAL ARTICLE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0032869324     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68275-4     Document Type: Article

References (18)

1. Schnall, M. D., Lenkinski, R. E., Pollack, H. M., Imai, Y. and Kressel, H. Y.: Prostate MR imaging with an endorectal surface coil. Radiology, 172: 57, 1989.
2. Perrotti, M., Kaufman, R. P., Jennings, T. A., Thaler, H. T, Soloway, S. M., Rifkin, M. D. and Fisher, H. A. G.: Endorectal coil MRI in clinically localized prostate cancer: Is it accurate? J. Urol., 156: 106, 1996.
3. Perrotti, M. and Fair, W. R.: Prostate cancer staging in the newly diagnosed patient. AUA update series, 16: 234, 1997.
4. Perrotti, M. and Fair, W. R.: Prostate cancer: Patient evaluation. In: Surgery of the Prostate. Edited by M. I. Resnick and I. M. Thompson. New York: Churchill Livingstone, pp 1-19, 1997.
5. Presti, J. C., Hricak, H., Narayan, P. A., Shinohara, K., White, S. and Carroll, P. R.: Local staging of prostatic carcinoma: Comparison of transrectal sonography and endorectal MR imaging. AJR, 166: 103, 1996.
6. Ikonen, S., Karkkainen, P., Kivisaari, L., Salo, J. O., Taari, K., Vehmas, T., Tervahartiala, P. and Rannikko, S.: Magnetic resonance imaging of clinically localized prostate cancer. J. Urol., 159: 915, 1998.
7. Ellis, J. H., Tempany, C., Sarin, M. S., Gatsonis, C., Rifkin, M. D. and McNeil, B. J.: MR imaging and sonography of early prostate cancer: Pathologic and imaging features that influence identification and diagnosis. AJR, 162: 865, 1994.
8. Littrup, P. J., Williams, C. R., Egglin, T. K. and Kane, R. A.: Determination of prostate volume with transrectal ultrasound for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology, 179: 49, 1991.
9. Platt, J. F., Bree, R. L. and Schwab, R. E.: The accuracy of CT in the staging of carcinoma of the prostate. AJR, 149: 315, 1987.
10. Engeler, C. E., Wasserman, N. F. and Zhang, G.: Preoperative assessment of prostatic carcinoma by computerized tomography: weaknesses and new perspectives. Urol., 40: 346, 1992.
11. Rifkin, M. D., Zerhouni, E. A., Gatsonis, C. A., Quint, L. E., Paushter, D. M., Epstein, J. I., Hamper, U., Walsh, P.C. and McNeil, B. J.: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: Results of a multi-institutional cooperative trial. New Engl. J. Med., 323: 621, 1990.
12. Aarnink, R. G., Beerlage, H. P., De La Rosette, J. J. M. C. H., Debruyne, F. M. J. and Wijkstra, H.: Transrectal ultrasound of the prostate: Innovations and future applications. J. Urol., 159: 1568, 1998.
13. Melchior, S. W. and Brawer, M. K.: Role of transrectal ultrasound and biopsy. J. Clin. Ultrasound., 24: 463, 1996.
14. Ellis, W.J. and Brawer, M. K.: Repeat prostate needle biopsy: Who needs it? J. Urol., 153: 1496, 1995.
15. Keetch, D. W., Catalona, W. J. and Smith, D.S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen levels. J. Urol., 151: 1571, 1994.
16. Keetch, D. W., McMurty, J. M., Smith, D. S., Andriole, G. L. and Catalona, W. J.: Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J. Urol., 156: 428, 1996.
17. Woodrum, D. L., Brawer, M. K., Partin, A. W., Catalona, W. J. and Southwick, P.C.: Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J. Urol., 159: 5, 1998.
18. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Riche, J. P, deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P.H., Subong, E. N. P., Parson, R. E., Gasior, G. H., Loveland, K. G. and Southwick, P.C.: Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer form benign prostatic disease. A prospective multicenter clinical trial. J.A.M.A., 279: 1542, 1998.